Literature DB >> 28371323

Neuroprotective effects of E-PodoFavalin-15999 (Atremorine®).

Alejandro Romero1, Esther Parada2,3, Laura González-Lafuente2,3, Victor Farré-Alins2,3, Eva Ramos1, Ramón Cacabelos4, Javier Egea2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28371323      PMCID： PMC6492656          DOI： 10.1111/cns.12693

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN： 1755-5930            Impact factor:   5.243


× No keyword cloud information.
  7 in total

1.  Poststress treatment with PNU282987 can rescue SH-SY5Y cells undergoing apoptosis via α7 nicotinic receptors linked to a Jak2/Akt/HO-1 signaling pathway.

Authors:  Esther Parada; Javier Egea; Alejandro Romero; Laura del Barrio; Antonio G García; Manuela G López
Journal:  Free Radic Biol Med       Date:  2010-09-26       Impact factor: 7.376

2.  Time Trends in the Incidence of Parkinson Disease.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Walter A Rocca
Journal:  JAMA Neurol       Date:  2016-08-01       Impact factor: 18.302

3.  Galantamine elicits neuroprotection by inhibiting iNOS, NADPH oxidase and ROS in hippocampal slices stressed with anoxia/reoxygenation.

Authors:  J Egea; M D Martín-de-Saavedra; E Parada; A Romero; L Del Barrio; A O Rosa; A G García; M G López
Journal:  Neuropharmacology       Date:  2011-11-09       Impact factor: 5.250

Review 4.  Current and experimental treatments of Parkinson disease: A guide for neuroscientists.

Authors:  Wolfgang Oertel; Jörg B Schulz
Journal:  J Neurochem       Date:  2016-08-30       Impact factor: 5.372

5.  Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma SH-SY5Y cells: Involvement of intracellular signaling pathways.

Authors:  M P Cunha; M D Martín-de-Saavedra; A Romero; E Parada; J Egea; L Del Barrio; A L S Rodrigues; M G López
Journal:  Neuroscience       Date:  2013-02-26       Impact factor: 3.590

Review 6.  Targets for neuroprotection in Parkinson's disease.

Authors:  Talene A Yacoubian; David G Standaert
Journal:  Biochim Biophys Acta       Date:  2008-10-01

7.  Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson's model.

Authors:  Mauricio Peña Cunha; Maria D Martín-de-Saavedra; Alejandro Romero; Javier Egea; Fabiana K Ludka; Carla I Tasca; Marcelo Farina; Ana Lúcia S Rodrigues; Manuela G López
Journal:  ASN Neuro       Date:  2014-11-24       Impact factor: 4.146
  7 in total
  1 in total

Review 1.  Nutrition, Health, and Disease: Role of Selected Marine and Vegetal Nutraceuticals.

Authors:  Lola Corzo; Lucía Fernández-Novoa; Iván Carrera; Olaia Martínez; Susana Rodríguez; Ramón Alejo; Ramón Cacabelos
Journal:  Nutrients       Date:  2020-03-11       Impact factor: 5.717
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.